{"contentid": 488169, "importid": NaN, "name": "Takeda initiates filing for dengue vaccine candidate in EU and endemic countries", "introduction": "Japan\u00e2\u0080\u0099s leading drugmaker Takeda says that the European Medicines Agency (EMA) has accepted the company\u00e2\u0080\u0099s filing packages for its dengue vaccine candidate (TAK-003) which is being investigated for the prevention of dengue due to any dengue virus serotype in individuals ages four to 60.", "content": "<p>Japan&rsquo;s leading drugmaker Takeda (TYO: 4502) says that the European Medicines Agency (EMA) has accepted the company&rsquo;s filing packages for its dengue vaccine candidate (TAK-003) which is being investigated for the prevention of dengue due to any dengue virus serotype in individuals ages four to 60.</p>\n<p>Takeda intends to submit regulatory filings in Argentina, Brazil, Colombia, Indonesia, Malaysia, Mexico, Singapore, Sri Lanka and Thailand during 2021.</p>\n<p>&ldquo;Submission of regulatory filings for our dengue vaccine candidate, TAK-003, marks an important development for people who are living in or traveling to communities burdened by the threat of dengue,&rdquo; said Derek Wallace, vice president, Dengue Global Program leader at Takeda.</p>\n<p>Takeda is participating in the EMA&rsquo;s first-ever parallel assessment of a medicinal product for use in the European Union, and through the EU-M4all (previously Article 58) procedure for countries outside of the EU.</p>\n<p>Along with the scientific opinion issued by the Committee for Medicinal Products for Human Use (CHMP), national regulators in countries participating in the EU-M4all procedure will conduct their own assessments to determine if national marketing authorizations for TAK-003 are granted. Takeda is also seeking approval of TAK-003 in dengue-endemic countries that are not participating in the EU-M4all procedure.</p>\n<p>Regulatory submissions for TAK-003 include long-term safety and efficacy data through 36 months from the ongoing pivotal Phase USA, followed by additional countries in Asia and Latin America.</p>\n<p>In December 2018, the European Commission granted marketing authorization for Dengvaxia (dengue tetravalent vaccine [live, attenuated]), from French pharma major Sanofi (Euronext: SAN), marking the first approval of a Dengue vaccine in Europe.</p>", "date": "2021-03-26 14:52:00", "meta_title": "Takeda initiates filing for dengue vaccine candidate in EU and endemic", "meta_keywords": "Takeda, TAK-003, Dengue, Vaccine, Filing, EMA, Endemic countries", "meta_description": "Takeda initiates filing for dengue vaccine candidate in EU and endemic countries", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 1, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-03-26 16:42:50", "updated": "2021-03-26 16:52:18", "access": NaN, "url": "https://www.thepharmaletter.com/article/takeda-initiates-filing-for-dengue-vaccine-candidate-in-eu-and-endemic-countries", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "dengue_mosquito_large.jpg", "image2id": "dengue_mosquito_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Pharmaceutical", "therapy area_tag": "Tropical diseases, Vaccines", "topic_tag": "Asia Pacific, European Medicines Agency, Focus On, Regulation", "geography_tag": "Europe, Japan", "company_tag": "Takeda", "drug_tag": "TAK-003", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-03-26 14:52:00"}